Genea’s commitment to pioneering and developing the fertility sector has been honoured this evening, competing against more than 1,000 organisations to be recognised as one of Australia’s most innovative companies. Genea has been listed in the 2017 Australian Financial Review’s Top 50 Most Innovative Companies list, ranked number 25. As the only fertility company on the Top 50 list, the AFR recognition is testament to Genea’s commitment to innovate IVF treatment, implementing world leading processes and developing ground-breaking technologies that support efficiencies in Genea laboratories and maximise the potential for patients to have a baby.
Genea CEO Dr Tomas Stojanov said; "Genea has worked hard to be leaders in the fertility technology sector, drawing on more than thirty one years’ experience in the IVF business to produce technologies we now share around the world." He added; "the AFR acknowledgement is further evidence that there is a difference between the technologies offered in IVF labs."
As a technology company with direct access to a world leading fertility lab, Genea is in a unique position to innovate, with insight into the needs and challenges of patients, doctors and scientists. These insights lead to new ideas, ways to improve technology and thoughts on how to streamline processes. As a result, laboratory innovations are then developed and commercialised which in turn sees improvements that are delivered to patients globally.
technologies are exclusive to Genea laboratories in Australia but shared with clinics around the world, key innovations include:
- Geri® - a benchtop incubator with individually controlled incubation chambers per patient to minimise disruptive events to the early-stage embryo. It also incorporates a camera for continuous monitoring of embryos as they develop which also facilitates continuous culture using the Geri Medium.
- Grow by Genea® - an Australian first app allowing patients 24/7 access to photos and videos of their embryos during the six days they spend growing in a Geri incubator in the embryology lab.
- Gavi® – the world’s first automated vitrification instrument. Vitrification is a process used in IVF to preserve embryos and eggs (oocytes) by cooling them rapidly to -180 degrees. Approaching the process in an innovative way, Gavi uses an automated, standardised protocol to provide consistent results in vitrification.
- Gems® - the latest generation of Genea’s culture media, the vital solution that supports embryo development outside the body. The Geri medium is also used with the Geri incubator offering a continuous culture system.
- Gidget® - an innovative tracking system that provides electronic witnessing, lab workflow management and support for traceability and audit reporting. Gidget provides assurance that each sample is correctly identified.
The AFR Top 50 Most Innovative Companies in Australia is one of the most prestigious awards, and ranks the most innovative organisations in Australia, across all industries. AFR’s assessment methodology is tough and rigorous to ensure only the most innovative of companies make the published list. Its method for evaluating the "innovativeness" of organisations uses both quantitative and qualitative data.